Given the therapeutic potential of A. dichotoma ALG9 in NAFLD, in the present study, we determined the function and mechanism of action of AGL9 with respect to reversing aberrant lipid metabolism and inflammation in the liver of NAFLD model mice fed a high-fat diet (HFD). Here, ALG9 is linked to metabolic dysfunction-associated steatotic liver disease.